Clinician walkthrough

Advanced Metabolic Health Assessment

A page-by-page look at the report your patient receives. This assessment uses the metabolic and diabetes sections of the full Cardiometabolic Risk Assessment and leaves out cardiovascular risk, for patients working on metabolic health first. The patient sees the same pages with plain-language explanations; this guide adds the methods and evidence behind them.

What goes into the report

  • Labcorp fasting panel: NMR LipoProfile with ApoB and the LP-IR Score, standard lipid panel, hemoglobin A1C, and fasting glucose.
  • Pre-assessment survey: anthropometrics, blood pressure, glucose and blood pressure history and treatment, family history of diabetes, and lipid medications.
  • Frameworks: harmonized metabolic syndrome criteria, the MetS severity score from MetS Calc, and the MESA-based diabetes risk model.

The LP-IR Score is not valid on a non-fasting sample, so the draw must be fasting.

Reading the scales

Every scale runs green (lower risk) to red (higher risk). Category labels follow the source guideline or model, so they differ by domain:

DomainCategories
LP-IR Score (30–80+ men, 25–70+ women)Optimal, Near Optimal, Intermediate, High, Very High
MetS severity percentileLow, Borderline, Intermediate, High
8-year T2D riskLow, Moderate, High, Very High
Hemoglobin A1CNormal, Pre-Diabetes, Diabetes

A white circle marks the current value; an X marks a category result. In follow-up reports a gray box marks the baseline value. In the metabolic syndrome table, yellow cells meet a criterion and red cells flag ApoB above the high-risk cutoff.

Methods at a glance

Each score in this report comes from a published method.

MeasureHow it is derivedRefs
LP-IR ScoreWeighted composite of six NMR lipoprotein measures: large VLDL-P, small LDL-P, large HDL-P, and mean VLDL, LDL, and HDL size. Scored 0 (most insulin sensitive) to 100 (most insulin resistant). The report’s category scale is sex-specific.1, 2
8-year T2D riskSex-specific probability of incident type 2 diabetes from the LP-IR Score and fasting glucose, based on the Multi-Ethnic Study of Atherosclerosis. LP-IR has also predicted diabetes in the Women’s Health Study, JUPITER, and PREVEND.3–6
MetS severity scoreSex- and race/ethnicity-specific continuous score from a confirmatory factor analysis of the five MetS components in NHANES adults, calculated with MetS Calc (metscalc.org). Reported as a percentile of U.S. adults. Higher scores predict incident diabetes, coronary heart disease, CVD, and ischemic stroke.9–16
Metabolic syndromeHarmonized criteria: waist above the sex- and ethnicity-specific cutoff, BP ≥130/85, fasting glucose ≥100, triglycerides ≥150, HDL-C <40 (men) or <50 (women), or drug treatment for that factor. Three or more criteria means metabolic syndrome.7, 8
ApoBMeasured on the NMR LipoProfile. Values above 110 mg/dL are flagged as an additional high-risk metabolic syndrome factor.20–22

Page by page

Click any sample page to see it larger. The sample is an initial report for a female patient, so the LP-IR scale shows the female range.

Sample page: Cover
Page 1

Cover

Patient, report date, and ordering provider.

  • Identifies the patient and the ordering clinician or organization
  • Frames the report as decision support for shared decision-making
Click anywhere to close
Sample page: Letter from the Chief Medical Officer
Page 2

Letter from the Chief Medical Officer

Frames metabolic health for the patient before the numbers.

  • Defines metabolic health as regulation of glucose, insulin, lipoprotein particles, and weight
  • Explains that risk accumulates silently and that many factors are modifiable
  • Positions the report as a tool for personalized diet, activity, and medication decisions
Click anywhere to close
Sample page: Metabolic Risk Details
Page 3

Metabolic Risk Details

Insulin resistance, metabolic syndrome criteria, and severity.

  • LP-IR Score on a sex-specific scale. It reflects the lipoprotein changes of insulin resistance: more large VLDL and small LDL particles, fewer large HDL particles, larger VLDL, and smaller LDL and HDL.
  • The five metabolic syndrome criteria with sex- and ethnicity-specific cutoffs. Criteria met are shaded yellow, and treatment for a factor counts as meeting it.
  • ApoB >110 mg/dL shaded red as an additional high-risk factor
  • MetS severity score (MetS Calc), reported as a sex- and race/ethnicity-specific percentile of U.S. adults
Because the severity score is continuous, it can show improvement from weight loss, activity, or treatment of individual components even when the yes/no criteria count doesn’t change.
Key references: 1, 2, 7–16
Click anywhere to close
Sample page: Diabetes Risk Details
Page 4

Diabetes Risk Details

Current glycemic status and forward-looking diabetes risk.

  • Hemoglobin A1C on a Normal, Pre-Diabetes, and Diabetes scale, with breakpoints at 5.7% and 6.5%
  • LP-IR Score with its category scale
  • Sex-specific 8-year probability of incident type 2 diabetes from LP-IR and fasting glucose (MESA), plotted on curves for minimum and maximum LP-IR across fasting glucose
At the same fasting glucose, predicted risk rises steeply with LP-IR, which makes insulin resistance the actionable target before dysglycemia appears.
Key references: 3–6, 23–28
Click anywhere to close
Sample page: Tracking Charts
Pages 5–7

Tracking Charts

Serial values for retesting.

  • Metabolic risk tracking: the five MetS components and the severity score at each test
  • Diabetes risk tracking: A1C, fasting glucose, LP-IR, and estimated 8-year risk
  • A QR code on the divider page links the patient to a reference page for every topic in the report
Each follow-up adds a point, which makes response to therapy visible to the patient.
Click anywhere to close
Sample page: Pre-Assessment Survey Responses
Page 8

Pre-Assessment Survey Responses

The patient-reported inputs behind the metabolic calculations.

  • Height, weight, waist, BMI, and blood pressure
  • Blood pressure and glucose history and treatment, and family history of diabetes
  • Current lipid medications
Self-reported waist and blood pressure can change a metabolic syndrome criterion and the severity score, so they are worth confirming.
Click anywhere to close
Sample page: Labcorp Lab Report
Final pages

Labcorp Lab Report

The complete Labcorp report, unaltered.

  • NMR LipoProfile: ApoB, the LP-IR Score and its six component measures, and the standard lipid panel
  • Hemoglobin A1C and fasting glucose
Lab flags use Labcorp’s general reference intervals.
Click anywhere to close

Follow-up reports

Follow-up reports keep the same structure and add the patient’s baseline beside each current value.

  • On every scale, a gray box marks the baseline value and a white circle marks the current value
  • The metabolic syndrome table shows baseline and current columns
  • Tracking charts add a point for each test
Baseline and current values on the metabolic page
Baseline and current values on the metabolic page
Click anywhere to close
Diabetes tracking across four tests
Diabetes tracking across four tests
Click anywhere to close

See it with your own patients

Ordering takes about 30 seconds, and we deliver the completed report in a few days. We’re happy to walk through a sample with you.

Book a call

Sample pages have all personal details removed. Reference numbers match the list on our references page. Precision Health Reports supports, and does not replace, clinical judgment.